Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Methods for Identifying Patients with Tropomyosin Receptor Kinase (TRK) Fusion Cancer
Derek Wong, Stephen Yip, Poul H. Sorensen
Pathology & Oncology Research (2019) Vol. 26, Iss. 3, pp. 1385-1399
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Next Generation Sequencing for Gene Fusion Analysis in Lung Cancer: A Literature Review
Rossella Bruno, Gabriella Fontanini
Diagnostics (2020) Vol. 10, Iss. 8, pp. 521-521
Open Access | Times Cited: 125
Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network
George D. Demetri, Cristina R. Antonescu, Bodil Bjerkehagen, et al.
Annals of Oncology (2020) Vol. 31, Iss. 11, pp. 1506-1517
Open Access | Times Cited: 124
NTRK Fusions Identified in Pediatric Tumors: The Frequency, Fusion Partners, and Clinical Outcome
Xiaonan Zhao, Chelsea Kotch, Elizabeth Fox, et al.
JCO Precision Oncology (2021), Iss. 5, pp. 204-214
Open Access | Times Cited: 68
Liquid biopsy and non-small cell lung cancer: are we looking at the tip of the iceberg?
Laura Bonanno, Alessandro Dal Maso, Alberto Pavan, et al.
British Journal of Cancer (2022) Vol. 127, Iss. 3, pp. 383-393
Open Access | Times Cited: 61
Molecular diagnosis and targeted treatment of advanced follicular cell-derived thyroid cancer in the precision medicine era
Jaume Capdevila, Ahmad Awada, Dagmar Führer‐Sakel, et al.
Cancer Treatment Reviews (2022) Vol. 106, pp. 102380-102380
Open Access | Times Cited: 50
NTRK Therapy among Different Types of Cancers, Review and Future Perspectives
Nyein Wint Yee Theik, Meri Muminovic, Andrés M. Alvarez-Pinzon, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2366-2366
Open Access | Times Cited: 10
NTRK Fusions, from the Diagnostic Algorithm to Innovative Treatment in the Era of Precision Medicine
Federica Zito Marino, Francesca Pagliuca, Andrea Ronchi, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 10, pp. 3718-3718
Open Access | Times Cited: 60
Larotrectinib Treatment for Patients With TRK Fusion-Positive Salivary Gland Cancers
Xiuning Le, Christina Baik, Jessica R. Bauman, et al.
The Oncologist (2022) Vol. 29, Iss. 6, pp. e779-e788
Open Access | Times Cited: 30
Guidance for clinicians and patients with non-small cell lung cancer in the time of precision medicine
Liza C. Villaruz, Mark A. Socinski, Jared Weiss
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 18
NTRK-rearranged mesenchymal tumours: diagnostic challenges, morphological patterns and proposed testing algorithm
Daniel Wong, Ana Cristina Vargas, Fiona Bonar, et al.
Pathology (2020) Vol. 52, Iss. 4, pp. 401-409
Closed Access | Times Cited: 43
NTRK Fusions and TRK Inhibitors: Potential Targeted Therapies for Adult Glioblastoma
Yuekun Wang, Piaopiao Long, Yu Wang, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 40
Highly sensitive fusion detection using plasma cell‐free RNA in non‐small‐cell lung cancers
Nobuhiko Hasegawa, Shinji Kohsaka, Kana Kurokawa, et al.
Cancer Science (2021) Vol. 112, Iss. 10, pp. 4393-4403
Open Access | Times Cited: 36
Roles of TrkC Signaling in the Regulation of Tumorigenicity and Metastasis of Cancer
Wook Jin
Cancers (2020) Vol. 12, Iss. 1, pp. 147-147
Open Access | Times Cited: 36
NTRK gene fusion testing and management in lung cancer
Matteo Repetto, Marina Chiara Garassino, Herbert H. Loong, et al.
Cancer Treatment Reviews (2024) Vol. 127, pp. 102733-102733
Open Access | Times Cited: 5
Actionable Structural Variant Detection via RNA-NGS and DNA-NGS in Patients With Advanced Non–Small Cell Lung Cancer
Dwight Owen, Rotem Ben‐Shachar, Josephine Feliciano, et al.
JAMA Network Open (2024) Vol. 7, Iss. 11, pp. e2442970-e2442970
Open Access | Times Cited: 4
Prognostic potential of fusion gene analysis using plasma cell-free RNA in malignant bone and soft tissue tumours
Naoki Furukawa, Nobuhiko Hasegawa, Daisuke Kubota, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
RNA hybrid-capture next-generation sequencing has high sensitivity in identifying known and less characterized oncogenic and likely oncogenic NTRK fusions in a real-world standard-of-care setting
Zachary D. Wallen, Marni Brisson Tierno, Erica Schnettler, et al.
Frontiers in Genetics (2025) Vol. 16
Open Access
Diagnosis and Management of Tropomyosin Receptor Kinase Fusion-Positive Thyroid Carcinomas
Robert I. Haddad, Rossella Elisei, Ana O. Hoff, et al.
JAMA Oncology (2023) Vol. 9, Iss. 8, pp. 1132-1132
Closed Access | Times Cited: 9
A case of quadruple wild-type gastrointestinal stromal tumor with CDC42BPB::NTRK3 fusion and abundant lymphoid infiltration
Wentao Xiang, Wei Yuan, Lei Ren, et al.
Diagnostic Pathology (2025) Vol. 20, Iss. 1
Open Access
Current Knowledge about Mechanisms of Drug Resistance against ALK Inhibitors in Non-Small Cell Lung Cancer
Elisabeth Smolle, Valentin Taucher, Joerg Lindenmann, et al.
Cancers (2021) Vol. 13, Iss. 4, pp. 699-699
Open Access | Times Cited: 20
Fusion transcript discovery using RNA sequencing in formalin-fixed paraffin-embedded specimen
Amin Talebi, Jean Paul Thiery, Mohammad Amin Kerachian
Critical Reviews in Oncology/Hematology (2021) Vol. 160, pp. 103303-103303
Closed Access | Times Cited: 18
Update on selected advances in the immunohistochemical and molecular genetic analysis of soft tissue tumors
Khin Thway, Andrew L. Folpe
Virchows Archiv (2019) Vol. 476, Iss. 1, pp. 3-15
Closed Access | Times Cited: 18
TRK Inhibitors in Non-Small Cell Lung Cancer
Guilherme Harada, Aline Bobato Lara Gongora, Cesar Martins da Costa, et al.
Current Treatment Options in Oncology (2020) Vol. 21, Iss. 5
Closed Access | Times Cited: 17
Updates in the molecular pathology of non-small cell lung cancer
Elizabeth Paver, Sandra O’Toole, Xin Cheng, et al.
Seminars in Diagnostic Pathology (2021) Vol. 38, Iss. 5, pp. 54-61
Closed Access | Times Cited: 15
Detection of Novel Tyrosine Kinase Fusion Genes as Potential Therapeutic Targets in Bone and Soft Tissue Sarcomas Using DNA/RNA-based Clinical Sequencing
Nobuhiko Hasegawa, Takuo Hayashi, Hidetaka Niizuma, et al.
Clinical Orthopaedics and Related Research (2023) Vol. 482, Iss. 3, pp. 549-563
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top